Edgewise Therapeutics (EWTX) News Today $13.41 +0.38 (+2.89%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$13.35 -0.06 (-0.42%) As of 04/17/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 9.4% - Here's What HappenedEdgewise Therapeutics (NASDAQ:EWTX) Shares Up 9.4% - Time to Buy?April 17 at 1:46 PM | marketbeat.comNew Leaf Venture Partners L.L.C. Sells 523,500 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)New Leaf Venture Partners L.L.C. cut its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 33.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,030,161 shares of the coApril 16 at 7:47 AM | marketbeat.com47,755 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Norges BankNorges Bank purchased a new stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 47,755 shares of the company's stock, valued at approxiApril 14, 2025 | marketbeat.comTrexquant Investment LP Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Trexquant Investment LP bought a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 74,781 shares of the company's stock, vApril 11, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month Low - What's Next?Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 1-Year Low - Here's What HappenedApril 10, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Stake Reduced by Vanguard Group Inc.Vanguard Group Inc. trimmed its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 1.1% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 4,466,849 shares of the company's stock after selling 49,214 shares during the quarter. Vanguard GApril 10, 2025 | marketbeat.comBiotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & MoreApril 10, 2025 | msn.comEdgewise Therapeutics, Inc. (EWTX): Among Stocks Insiders Bought in April After Trump’s Tariff RolloutApril 8, 2025 | insidermonkey.comEdgewise Therapeutics, Inc. (EWTX): Among Stocks Insiders Bought in April After Trump’s Tariff RolloutApril 8, 2025 | msn.comThese 5 Insiders Are Buying During Market ChaosApril 8, 2025 | 247wallst.com93,061 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Acquired by Schroder Investment Management GroupSchroder Investment Management Group bought a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 93,061 shares of the company's stock, valApril 8, 2025 | marketbeat.comWedbush Lowers Earnings Estimates for Edgewise TherapeuticsApril 8, 2025 | americanbankingnews.comLeerink Partnrs Has Bullish Forecast for EWTX Q1 EarningsApril 8, 2025 | americanbankingnews.comLeerink Partnrs Has Strong Estimate for EWTX Q1 EarningsEdgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) - Research analysts at Leerink Partnrs lifted their Q1 2025 earnings estimates for Edgewise Therapeutics in a report released on Wednesday, April 2nd. Leerink Partnrs analyst J. Schwartz now forecasts that the company will post earnings perApril 8, 2025 | marketbeat.comQ1 EPS Estimates for Edgewise Therapeutics Cut by WedbushEdgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) - Equities research analysts at Wedbush reduced their Q1 2025 EPS estimates for Edgewise Therapeutics in a research note issued to investors on Wednesday, April 2nd. Wedbush analyst L. Chico now anticipates that the company will post earningApril 8, 2025 | marketbeat.comInsider Buying: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Director Purchases 496,771 Shares of StockEdgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) Director Orbimed Advisors Llc bought 496,771 shares of the company's stock in a transaction dated Thursday, April 3rd. The stock was acquired at an average price of $20.13 per share, for a total transaction of $10,000,000.23. Following the acquisition, the director now directly owns 14,809,075 shares in the company, valued at $298,106,679.75. This trade represents a 3.47 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.April 6, 2025 | marketbeat.comCinctive Capital Management LP Has $376,000 Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Cinctive Capital Management LP decreased its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 81.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,093 shares of the company's stock afteApril 6, 2025 | marketbeat.comEdgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your MoneyApril 5, 2025 | msn.comEdgewise Therapeutics (NASDAQ:EWTX) Sees Unusually-High Trading Volume - Time to Buy?Edgewise Therapeutics (NASDAQ:EWTX) Sees Strong Trading Volume - Still a Buy?April 5, 2025 | marketbeat.comRoyal Bank of Canada Lowers Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $52.00Royal Bank of Canada dropped their price target on shares of Edgewise Therapeutics from $56.00 to $52.00 and set an "outperform" rating on the stock in a research report on Thursday.April 5, 2025 | marketbeat.comOrbimed Advisors Llc Purchases 496,771 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) StockApril 5, 2025 | insidertrades.comPictet Asset Management Holding SA Takes $8.04 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Pictet Asset Management Holding SA purchased a new position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 301,241 shares of the company's stocApril 5, 2025 | marketbeat.comPiper Sandler Reiterates Overweight Rating for Edgewise Therapeutics (NASDAQ:EWTX)Piper Sandler restated an "overweight" rating and issued a $51.00 price objective on shares of Edgewise Therapeutics in a research note on Wednesday.April 4, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Lowered to Sector Perform Rating by ScotiabankScotiabank cut shares of Edgewise Therapeutics from a "sector outperform" rating to a "sector perform" rating and set a $14.00 target price on the stock. in a research note on Wednesday.April 4, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Rating Lowered to "Sector Perform" at ScotiabankScotiabank cut shares of Edgewise Therapeutics from a "sector outperform" rating to a "sector perform" rating and set a $14.00 target price for the company. in a research note on Wednesday.April 4, 2025 | marketbeat.comInvestors Buy High Volume of Put Options on Edgewise Therapeutics (NASDAQ:EWTX)Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Stock traders bought 13,313 put options on the stock. This is an increase of approximately 873% compared to the average daily volume of 1,368 put options.April 4, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month Low - Should You Sell?Edgewise Therapeutics (NASDAQ:EWTX) Hits New 1-Year Low - Should You Sell?April 4, 2025 | marketbeat.comScotiabank Downgrades Edgewise Therapeutics (EWTX)April 4, 2025 | msn.comEdgewise downgraded yesterday at Scotiabank after CIRRUS-HCM readoutApril 3, 2025 | markets.businessinsider.comEdgewise Therapeutics (NASDAQ:EWTX) Shares Down 7.3% - Should You Sell?Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 7.3% - Time to Sell?April 3, 2025 | marketbeat.comEdgewise Therapeutics downgraded to Sector Perform from Outperform at ScotiabankApril 3, 2025 | markets.businessinsider.comEdgewise Therapeutics: Despite AF Safety Issues, EDG-7500 Advancement Presses OnApril 2, 2025 | seekingalpha.comEdgewise Therapeutics stock tumbles after trial results and stock offeringApril 2, 2025 | in.investing.comEdgewise Therapeutics falls after pricing $200M offeringApril 2, 2025 | msn.comEdgewise Therapeutics Stock Plummets on Drug Trial 'Adverse Events'April 2, 2025 | msn.comWhy Edgewise Therapeutics And Cytokinetics Stocks Just DivergedApril 2, 2025 | investors.comEdgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common StockApril 2, 2025 | prnewswire.comEdgewise Therapeutics Announces Positive Top-Line Results from Phase 2 CIRRUS-HCM Four-Week Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM)April 2, 2025 | prnewswire.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by American Century Companies Inc.American Century Companies Inc. cut its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 17.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 770,353 shares of the company's stock after seMarch 31, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Holdings Raised by Artisan Partners Limited PartnershipArtisan Partners Limited Partnership grew its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 7.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,071,596 sharMarch 30, 2025 | marketbeat.comEdgewise Therapeutics (NASDAQ:EWTX) Trading Up 9.3% - Should You Buy?Edgewise Therapeutics (NASDAQ:EWTX) Trading 9.3% Higher - Here's WhyMarch 28, 2025 | marketbeat.comEFG Asset Management North America Corp. Takes $1.10 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)EFG Asset Management North America Corp. bought a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 41,3March 27, 2025 | marketbeat.comEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Average Recommendation of "Moderate Buy" by BrokeragesEdgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight research firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold rating and seven have issued a buy rating onMarch 27, 2025 | marketbeat.comEdgewise Therapeutics to Host Webcast Event to Discuss Top-Line Results from Phase 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Eastern TimeMarch 26, 2025 | prnewswire.comRelative Strength Alert For Edgewise TherapeuticsMarch 26, 2025 | nasdaq.comTruist Financial Keeps Their Buy Rating on Edgewise Therapeutics (EWTX)March 24, 2025 | markets.businessinsider.comIntech Investment Management LLC Buys 14,944 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Intech Investment Management LLC increased its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 75.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,844 shares of the company's stock afterMarch 24, 2025 | marketbeat.comTruist maintains Buy rating on Edgewise Therapeutics stockMarch 23, 2025 | uk.investing.comVictory Capital Management Inc. Purchases Shares of 21,568 Edgewise Therapeutics, Inc. (NASDAQ:EWTX)Victory Capital Management Inc. acquired a new stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,568 shares of the company's stock, valued at approximately $5March 22, 2025 | marketbeat.comEWTX Makes Notable Cross Below Critical Moving AverageMarch 21, 2025 | nasdaq.com Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address EWTX Media Mentions By Week EWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EWTX News Sentiment▼1.080.49▲Average Medical News Sentiment EWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EWTX Articles This Week▼35▲EWTX Articles Average Week Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Telix Pharmaceuticals Limited American Depositary Shares News Today Axsome Therapeutics News Today Krystal Biotech News Today Nuvalent News Today Grifols News Today Elanco Animal Health News Today Verona Pharma News Today ADMA Biologics News Today Cytokinetics News Today Vaxcyte News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EWTX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EWTX Stock Free EWTX Stock Alerts